Search results

• Finished

  COVID-19: RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

  Simmons, C. (PI) & Whiteheart, S. (CoI)

  Duke University

  2/27/24 → 2/27/24

  Project: Research project

  • Sequela 100%
  • Infection 100%
  • Severe Acute Respiratory Syndrome Coronavirus 2 100%
  • Sleep Disorder 100%
  • COVID-19 100%

• Start Up Costs Only: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2a Study for Safety and Immunogenicity Evaluations of Various RSV.preF-based Vaccine Formulations in Adults Aged 60 Years and Older

  Greenberg, R. (PI), Caudill, T. (CoI) & Simmons, C. (CoI)

  Janssen Research and Development LLC

  9/13/23 → 10/13/23

  Project: Research project

• Covid 19: A Randomized, Double-blind, Phase 2 Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Ad26.COV2.S Administered as Booster Vaccination in Adults 18 Years of Age and Older Who Have Previously Received Primary Vaccination with Ad26

  Greenberg, R. (PI), Caudill, T. (CoI) & Simmons, C. (CoI)

  Janssen Vaccines and Prevention BV

  7/26/21 → 6/28/23

  Project: Research project

• Covid 19: A Phase 2/3, Two-Part, Open-Label, Dose-Escalation, Age De-escalation and Randomized, Oberver-Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine

  Fuchs, G. (PI), Bauer, J. (CoI), Desai, N. (CoI), Greenberg, R. (CoI), Robbins, S. (CoI), Simmons, C. (CoI) & Wurth, M. (CoI)

  PPD Investigator Services LLC

  6/16/21 → 1/7/25

  Project: Research project

• Covid 19: CoVPN 3006 Protocol Funding (PF) - Lexington Protocol-Specific Site

  Greenberg, R. (PI), Kern, P. (CoI) & Simmons, C. (CoI)

  Fred Hutchinson Cancer Research Center

  4/15/21 → 11/30/22

  Project: Research project

  • Severe Acute Respiratory Syndrome Coronavirus 2 100%
  • COVID-19 Vaccine 100%
  • Infection 100%
  • SARS Coronavirus 100%
  • Vaccine Efficacy 50%

• Covid 19: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older

  Greenberg, R. (PI), Kern, P. (CoI), Simmons, C. (CoI), Caudill, T. (Former CoI) & Englert, B. (Former CoI)

  Janssen Vaccines and Prevention BV

  2/5/21 → 12/31/24

  Project: Research project

• Covid 19: CoVID-19 Prevention Network (CoVPN) Site Preparedness Funding - Lexington Protocol-Specific Site

  Greenberg, R. (PI), Kern, P. (CoI) & Simmons, C. (CoI)

  Fred Hutchinson Cancer Research Center

  2/1/21 → 11/30/21

  Project: Research project

  • Patient Referral 100%
  • Clinical Trial 100%
  • Infection 50%
  • Study Participant 50%